Does the media prefer HSIC or COO?

In the previous week, Cooper Companies had 14 more articles in the media than Henry Schein. MarketBeat recorded 23 mentions for Cooper Companies and 9 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.52 beat Cooper Companies' score of 0.86 indicating that Henry Schein is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Cooper Companies 11 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IDXX or HSIC?

In the previous week, Henry Schein had 6 more articles in the media than IDEXX Laboratories. MarketBeat recorded 9 mentions for Henry Schein and 3 mentions for IDEXX Laboratories. Henry Schein's average media sentiment score of 1.52 beat IDEXX Laboratories' score of 0.94 indicating that Henry Schein is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has preferable valuation & earnings, MASI or HSIC?

Henry Schein has higher revenue and earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Masimo $1.56B 6.05 -$151.50M -$10.54 N/A Henry Schein $13.18B 0.70 $398M $3.31 24.55

Is MASI or HSIC more profitable?

Masimo has a net margin of 4.90% compared to Henry Schein's net margin of 2.95%. Masimo's return on equity of 31.33% beat Henry Schein's return on equity. Company Net Margins Return on Equity Return on Assets Masimo 4.90% 31.33% 13.93% Henry Schein 2.95% 15.44% 5.53%

Does the media prefer MASI or HSIC?

In the previous week, Henry Schein had 1 more articles in the media than Masimo. MarketBeat recorded 9 mentions for Henry Schein and 8 mentions for Masimo. Henry Schein's average media sentiment score of 1.52 beat Masimo's score of 0.39 indicating that Henry Schein is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Masimo 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Henry Schein 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer MMSI or HSIC?

In the previous week, Henry Schein had 3 more articles in the media than Merit Medical Systems. MarketBeat recorded 9 mentions for Henry Schein and 6 mentions for Merit Medical Systems. Henry Schein's average media sentiment score of 1.52 beat Merit Medical Systems' score of 1.13 indicating that Henry Schein is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor HSIC or AMN?

In the previous week, Henry Schein had 7 more articles in the media than AMN Healthcare Services. MarketBeat recorded 9 mentions for Henry Schein and 2 mentions for AMN Healthcare Services. Henry Schein's average media sentiment score of 1.52 beat AMN Healthcare Services' score of 0.45 indicating that Henry Schein is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive AMN Healthcare Services 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Henry Schein (HSIC) Competitors

$81.25 0.00 (0.00%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$81.31 +0.06 (+0.08%)

As of 06/12/2026 07:27 PM Eastern

Compare

HSIC vs. COO, IDXX, MASI, MMSI, and AMN

Should you buy Henry Schein stock or one of its competitors? MarketBeat compares Henry Schein with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Henry Schein include Cooper Companies (COO), IDEXX Laboratories (IDXX), Masimo (MASI), Merit Medical Systems (MMSI), and AMN Healthcare Services (AMN). These companies are all part of the "medical" sector.

How does Henry Schein compare to Cooper Companies?

Henry Schein (NASDAQ:HSIC) and Cooper Companies (NASDAQ:COO) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

In the previous week, Cooper Companies had 14 more articles in the media than Henry Schein. MarketBeat recorded 23 mentions for Cooper Companies and 9 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.52 beat Cooper Companies' score of 0.86 indicating that Henry Schein is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	7 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Cooper Companies	11 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Henry Schein has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market.

Henry Schein has higher revenue and earnings than Cooper Companies. Henry Schein is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.70	$398M	$3.31	24.55
Cooper Companies	$4.09B	3.23	$374.90M	$1.18	57.53

Henry Schein currently has a consensus target price of $87.85, indicating a potential upside of 8.12%. Cooper Companies has a consensus target price of $82.64, indicating a potential upside of 21.75%. Given Cooper Companies' higher probable upside, analysts plainly believe Cooper Companies is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43
Cooper Companies	3 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.41

Cooper Companies has a net margin of 5.57% compared to Henry Schein's net margin of 2.95%. Henry Schein's return on equity of 15.44% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.95%	15.44%	5.53%
Cooper Companies	5.57%	10.88%	7.27%

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by company insiders. Comparatively, 2.1% of Cooper Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Cooper Companies beats Henry Schein on 10 of the 17 factors compared between the two stocks.

How does Henry Schein compare to IDEXX Laboratories?

IDEXX Laboratories (NASDAQ:IDXX) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

IDEXX Laboratories has a net margin of 24.63% compared to Henry Schein's net margin of 2.95%. IDEXX Laboratories' return on equity of 70.87% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	24.63%	70.87%	32.56%
Henry Schein	2.95%	15.44%	5.53%

In the previous week, Henry Schein had 6 more articles in the media than IDEXX Laboratories. MarketBeat recorded 9 mentions for Henry Schein and 3 mentions for IDEXX Laboratories. Henry Schein's average media sentiment score of 1.52 beat IDEXX Laboratories' score of 0.94 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	7 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

IDEXX Laboratories presently has a consensus target price of $751.00, indicating a potential upside of 33.90%. Henry Schein has a consensus target price of $87.85, indicating a potential upside of 8.12%. Given IDEXX Laboratories' stronger consensus rating and higher probable upside, equities research analysts plainly believe IDEXX Laboratories is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.64
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by company insiders. Comparatively, 0.9% of Henry Schein shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

IDEXX Laboratories has higher earnings, but lower revenue than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	10.28	$1.06B	$13.58	41.30
Henry Schein	$13.18B	0.70	$398M	$3.31	24.55

IDEXX Laboratories has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market. Comparatively, Henry Schein has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market.

Summary

IDEXX Laboratories beats Henry Schein on 10 of the 15 factors compared between the two stocks.

How does Henry Schein compare to Masimo?

Masimo (NASDAQ:MASI) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

86.0% of Masimo shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 9.7% of Masimo shares are owned by insiders. Comparatively, 0.9% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Masimo presently has a consensus price target of $180.40, suggesting a potential upside of 0.25%. Henry Schein has a consensus price target of $87.85, suggesting a potential upside of 8.12%. Given Henry Schein's stronger consensus rating and higher probable upside, analysts plainly believe Henry Schein is more favorable than Masimo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Masimo	0 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43

Masimo has a beta of 1.11, indicating that its stock price is 11% more volatile than the broader market. Comparatively, Henry Schein has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

Henry Schein has higher revenue and earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Masimo	$1.56B	6.05	-$151.50M	-$10.54	N/A
Henry Schein	$13.18B	0.70	$398M	$3.31	24.55

In the previous week, Henry Schein had 1 more articles in the media than Masimo. MarketBeat recorded 9 mentions for Henry Schein and 8 mentions for Masimo. Henry Schein's average media sentiment score of 1.52 beat Masimo's score of 0.39 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Masimo	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Henry Schein	7 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Masimo has a net margin of 4.90% compared to Henry Schein's net margin of 2.95%. Masimo's return on equity of 31.33% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Masimo	4.90%	31.33%	13.93%
Henry Schein	2.95%	15.44%	5.53%

Summary

Henry Schein beats Masimo on 10 of the 16 factors compared between the two stocks.

How does Henry Schein compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

In the previous week, Henry Schein had 3 more articles in the media than Merit Medical Systems. MarketBeat recorded 9 mentions for Henry Schein and 6 mentions for Merit Medical Systems. Henry Schein's average media sentiment score of 1.52 beat Merit Medical Systems' score of 1.13 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	7 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Henry Schein has higher revenue and earnings than Merit Medical Systems. Henry Schein is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	2.62	$128.49M	$2.31	28.80
Henry Schein	$13.18B	0.70	$398M	$3.31	24.55

Merit Medical Systems has a net margin of 9.03% compared to Henry Schein's net margin of 2.95%. Henry Schein's return on equity of 15.44% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.03%	13.54%	7.94%
Henry Schein	2.95%	15.44%	5.53%

Merit Medical Systems has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market.

Merit Medical Systems presently has a consensus price target of $92.80, indicating a potential upside of 39.49%. Henry Schein has a consensus price target of $87.85, indicating a potential upside of 8.12%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, equities analysts plainly believe Merit Medical Systems is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 0.9% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Merit Medical Systems and Henry Schein tied by winning 8 of the 16 factors compared between the two stocks.

How does Henry Schein compare to AMN Healthcare Services?

Henry Schein (NASDAQ:HSIC) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

Henry Schein has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.70	$398M	$3.31	24.55
AMN Healthcare Services	$2.73B	0.44	-$95.70M	-$0.87	N/A

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Henry Schein presently has a consensus target price of $87.85, suggesting a potential upside of 8.12%. AMN Healthcare Services has a consensus target price of $25.29, suggesting a potential downside of 17.87%. Given Henry Schein's stronger consensus rating and higher probable upside, equities analysts plainly believe Henry Schein is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

In the previous week, Henry Schein had 7 more articles in the media than AMN Healthcare Services. MarketBeat recorded 9 mentions for Henry Schein and 2 mentions for AMN Healthcare Services. Henry Schein's average media sentiment score of 1.52 beat AMN Healthcare Services' score of 0.45 indicating that Henry Schein is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	7 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
AMN Healthcare Services	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Henry Schein has a net margin of 2.95% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.95%	15.44%	5.53%
AMN Healthcare Services	-0.95%	18.01%	5.19%

Henry Schein has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.44, indicating that its stock price is 56% less volatile than the broader market.

Summary

Henry Schein beats AMN Healthcare Services on 13 of the 16 factors compared between the two stocks.

Get Henry Schein News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSIC vs. The Competition

Export

Metric	Henry Schein	MED/DENTAL Industry	Medical Sector	NASDAQ Exchange
Market Cap	$9.26B	$16.04B	$6.74B	$12.07B
Dividend Yield	N/A	1.20%	2.67%	5.67%
P/E Ratio	24.55	18.58	24.21	24.42
Price / Sales	0.70	2.28	512.04	109.94
Price / Cash	10.44	13.81	27.48	37.92
Price / Book	2.45	3.27	10.66	6.83
Net Income	$398M	$534.24M	$3.57B	$337.67M
7 Day Performance	4.10%	-0.17%	0.58%	1.17%
1 Month Performance	11.73%	8.67%	1.54%	3.16%
1 Year Performance	15.76%	3.15%	25.40%	30.58%

Henry Schein Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSIC Henry Schein	3.5065 of 5 stars	$81.25 flat	$87.85 +8.1%	+15.8%	$9.26B	$13.18B	24.55	25,000	Positive News
COO Cooper Companies	3.516 of 5 stars	$66.79 -0.8%	$82.64 +23.7%	-2.6%	$13.14B	$4.09B	56.60	15,000	Analyst Downgrade High Trading Volume
IDXX IDEXX Laboratories	3.7791 of 5 stars	$561.17 -0.2%	$751.00 +33.8%	+7.3%	$44.34B	$4.45B	41.32	11,000	Analyst Upgrade
MASI Masimo	1.8722 of 5 stars	$179.94 +0.6%	$180.40 +0.3%	N/A	$9.36B	$1.56B	N/A	2,200
MMSI Merit Medical Systems	4.5365 of 5 stars	$66.03 +2.4%	$92.80 +40.5%	-28.4%	$3.85B	$1.52B	28.58	7,500	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HSIC) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Henry Schein (HSIC) Competitors

HSIC vs. COO, IDXX, MASI, MMSI, and AMN

How does Henry Schein compare to Cooper Companies?

Summary

How does Henry Schein compare to IDEXX Laboratories?

Summary

How does Henry Schein compare to Masimo?

Summary

How does Henry Schein compare to Merit Medical Systems?

Summary

How does Henry Schein compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSIC vs. The Competition

Henry Schein Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Henry Schein (HSIC) Competitors

HSIC vs. COO, IDXX, MASI, MMSI, and AMN

How does Henry Schein compare to Cooper Companies?

Does the media prefer HSIC or COO?

Which has more volatility & risk, HSIC or COO?

Which has better valuation & earnings, HSIC or COO?

Do analysts recommend HSIC or COO?

Is HSIC or COO more profitable?

Do institutionals & insiders have more ownership in HSIC or COO?

Summary

How does Henry Schein compare to IDEXX Laboratories?

Is IDXX or HSIC more profitable?

Does the media favor IDXX or HSIC?

Do analysts recommend IDXX or HSIC?

Do insiders and institutionals have more ownership in IDXX or HSIC?

Which has higher valuation & earnings, IDXX or HSIC?

Which has more risk & volatility, IDXX or HSIC?

Summary

How does Henry Schein compare to Masimo?

Do insiders and institutionals hold more shares of MASI or HSIC?

Do analysts recommend MASI or HSIC?

Which has more risk & volatility, MASI or HSIC?

Which has preferable valuation & earnings, MASI or HSIC?

Does the media prefer MASI or HSIC?

Is MASI or HSIC more profitable?

Summary

How does Henry Schein compare to Merit Medical Systems?

Does the media prefer MMSI or HSIC?

Which has stronger valuation & earnings, MMSI or HSIC?

Is MMSI or HSIC more profitable?

Which has more risk & volatility, MMSI or HSIC?

Do analysts prefer MMSI or HSIC?

Do institutionals & insiders believe in MMSI or HSIC?

Summary

How does Henry Schein compare to AMN Healthcare Services?

Which has better earnings & valuation, HSIC or AMN?

Do insiders and institutionals hold more shares of HSIC or AMN?

Do analysts rate HSIC or AMN?

Does the media favor HSIC or AMN?

Is HSIC or AMN more profitable?

Which has more risk and volatility, HSIC or AMN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSIC vs. The Competition

Henry Schein Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools